Francisco Miguel Sánchez Margallo Honored with 2024 Translational Medicine Award for Pioneering Work in Surgery and Regenerative Medicine
Francisco Miguel Sánchez Margallo, a native of Albalá and a leading figure in the field of modern surgery, has been awarded the prestigious 2024 Translational Medicine Award by the Royal National Academy of Medicine of Spain (RANME). This accolade recognizes his remarkable contributions to minimally invasive surgery, robotic surgery, bioprinting, and regenerative medicine, marking a milestone in his illustrious career.
With over 30 years of experience, Sánchez Margallo serves as the scientific director of the Jesús Usón Minimally Invasive Surgery Center (CCMIJU).Under his leadership, the center has achieved groundbreaking milestones, including its participation in Spain’s first robotic lung transplant on humans. his innovative spirit is further evidenced by his 500+ presentations at international conferences, 300+ scientific publications, 25 edited books, and 17 registered patents.
Sánchez margallo’s influence extends beyond the operating room. He has positioned extremadura as a hub for biotechnology and health innovation by integrating the CCMIJU into the NANBIOSIS Singular Scientific-Technical Infrastructure (ICTS). His leadership in international projects like TREMIRS and MIREIA, which focus on medical robotics and biotechnology in surgery, has cemented his reputation as a global leader in the field.
in academia, Dr. Sánchez Margallo has supervised 35 doctoral theses and coordinates master’s programs in minimally invasive surgery. His efforts have strengthened the connection between research and clinical practice, ensuring that advancements in the lab translate into real-world medical solutions.
As president of the Spanish Society of Surgical Research (SEIQ), Sánchez Margallo organized the iSMIT International Congress in Cáceres in 2024. This event brought together leading experts in surgery and bioengineering, further establishing Extremadura as a global center for medical innovation.
The 2024 Translational Medicine Award not only celebrates Dr. Sánchez Margallo’s achievements but also highlights the transformative impact of the CCMIJU on modern surgery. It underscores Extremadura’s growing prominence in international medical science and innovation.
| Key Achievements of dr. Francisco Miguel Sánchez Margallo |
|—————————————————————|
| Award: 2024 Translational Medicine Award |
| Role: Scientific Director, CCMIJU |
| Milestones: First robotic lung transplant in Spain |
| Publications: 300+ scientific papers |
| Patents: 17 registered inventions |
| Projects: Leader of TREMIRS and MIREIA |
| Academic Contributions: 35 doctoral theses supervised |
Dr. Sánchez Margallo’s work continues to inspire the next generation of medical professionals, proving that innovation and dedication can reshape the future of healthcare.
Dr.Francisco Miguel Sánchez Margallo on the 2024 Translational Medicine Award adn Innovations in Surgery
Table of Contents
In a groundbreaking acknowledgment of his transformative contributions to the field of surgery and regenerative medicine, Dr. Francisco Miguel Sánchez Margallo has been honored with the 2024 Translational Medicine Award by the Royal National Academy of Medicine of Spain (RANME). With over 30 years of experience, Dr. Sánchez Margallo has pioneered advancements in minimally invasive surgery, robotic surgery, and bioprinting, reshaping the future of healthcare. In this exclusive interview, we sit down with Dr.Elena Morales, a renowned medical researcher, to delve into Dr. Sánchez Margallo’s remarkable achievements and the impact of his work on the medical community.
Breaking Boundaries in Minimally Invasive Surgery
Senior Editor: Dr. Morales, could you start by explaining the importance of Dr. Sánchez Margallo’s work in minimally invasive surgery?
Dr. Morales: Absolutely. Dr. Sánchez Margallo has been a trailblazer in minimally invasive surgery, a field that prioritizes smaller incisions, reduced patient recovery times, and lower risk of complications. His leadership at the Jesús Usón Minimally Invasive Surgery Center (CCMIJU) has been instrumental in advancing techniques that are now standard in operating rooms worldwide.for exmaple, his contributions to Spain’s first robotic lung transplant represent a monumental leap in the field.
The Role of Robotic surgery and Bioprinting
Senior Editor: How has Dr.Sánchez Margallo integrated robotic surgery and bioprinting into his work?
Dr. Morales: Robotic surgery and bioprinting are two areas where Dr. Sánchez Margallo has truly excelled. Robotic surgery allows for greater precision and control, which is particularly vital in complex procedures like organ transplants.Bioprinting, on the other hand, opens up new possibilities in regenerative medicine by enabling the creation of tissues and organs. His patented innovations in these areas are not just theoretical—they’re being applied in real-world clinical settings, improving patient outcomes and pushing the boundaries of what’s medically possible.
International Leadership and Collaboration
Senior Editor: Can you speak about his role in international projects like TREMIRS and MIREIA?
Dr. Morales: Dr. Sánchez Margallo’s leadership in projects like TREMIRS (focused on medical robotics) and MIREIA (dedicated to biotechnology in surgery) has been transformative. These initiatives bring together experts from around the globe to tackle some of the most pressing challenges in medicine. By fostering collaboration, he’s not only advancing research but also ensuring that these innovations are accessible to patients everywhere. His work has positioned Extremadura as a global hub for medical innovation.
Mentorship and Academic Contributions
Senior Editor: How has Dr. Sánchez Margallo contributed to the academic community?
Dr.Morales: His academic contributions are as remarkable as his clinical work. He has supervised 35 doctoral theses and coordinates master’s programs in minimally invasive surgery, bridging the gap between research and practice. By mentoring the next generation of medical professionals, he’s ensuring that his legacy of innovation and dedication continues to inspire future breakthroughs.
The 2024 Translational Medicine Award
Senior Editor: What does the 2024 Translational Medicine Award mean for Dr. Sánchez Margallo and the field of medicine?
Dr. Morales: This award is a testament to Dr. Sánchez Margallo’s unwavering commitment to advancing medicine. it recognizes not just his individual achievements but also the collective impact of his work on healthcare globally. By translating cutting-edge research into practical solutions, he’s reshaping the future of surgery and regenerative medicine, and this accolade underscores the importance of his contributions.
senior Editor: Thank you, Dr. Morales, for sharing these insights into Dr. Sánchez margallo’s unusual career and the significance of his work.
Dr. Morales: It was my pleasure. Dr. Sánchez Margallo’s story is a powerful reminder of how innovation and dedication can transform lives.
